Vanadyl sulfate-enhanced oncolytic virus immunotherapy mediates the antitumor immune response by upregulating the secretion of pro-inflammatory cytokines and chemokines

Oncolytic viruses (OVs) are promising anticancer treatments that specifically replicate in and kill cancer cells and have profound immunostimulatory effects. We previously reported the potential of vanadium-based compounds such as vanadyl sulfate (VS) as immunostimulatory enhancers of OV immunothera...

Descripción completa

Detalles Bibliográficos
Autores principales: Alluqmani, Nouf, Jirovec, Anna, Taha, Zaid, Varette, Oliver, Chen, Andrew, Serrano, Daniel, Maznyi, Glib, Khan, Sarwat, Forbes, Nicole E., Arulanandam, Rozanne, Auer, Rebecca C., Diallo, Jean-Simon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9749062/
https://www.ncbi.nlm.nih.gov/pubmed/36532027
http://dx.doi.org/10.3389/fimmu.2022.1032356

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9749062/
https://www.ncbi.nlm.nih.gov/pubmed/36532027
http://dx.doi.org/10.3389/fimmu.2022.1032356

Ejemplares similares